Impact of artificial intelligence on breast care pathways and future perspectives
DOI:
https://doi.org/10.29289/259453942025008Palavras-chave:
artificial intelligence, breast cancer, mastologyResumo
Artificial intelligence (AI) is a sophisticated technology already established in medicine. In mastology, there is robust evidence of the ability of AI software to optimize screening, reduce interval cancer rates, and decrease patient recall rates. In addition, AI provides parameters for predicting surgical complications and oncological therapeutic outcomes. Considering the rise of AI, this article aimed to conduct an integrative review, highlighting its main tools developed in mastology. A search was performed on the United States National Library of Medicine (PubMed) platform, using descriptors associated with AI and breast cancer. Retrospective studies, systematic reviews, and prospective clinical studies published in English in the last ten years were included. The results were organized by thematic areas and summarized in a table and the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) flowchart. Data analysis showed a concentration of information in the area of imaging — with advances in radiomics — and a still incipient, albeit promising, development in areas such as genetics and surgery. The article highlights the need for discussion on the ethical issues surrounding the implementation of AI. The reliability of data collection and manipulation must be guaranteed, and data automation should not imply automation of conduct, since medical responsibility in patient care is perennial.
Downloads
Referências
1. Bhinder B, Gilvary C, Madhukar NS, Elemento O. Artificial intelligence in cancer research and precision medicine. Cancer Discov. 2021;11(4):900-15. https://doi.org/10.1158/2159-8290.CD-21-0090
2. Kaul V, Enslin S, Gross SA. History of artificial intelligence in medicine. Gastrointest Endosc. 2020;92(4):807-12. https://doi.org/10.1016/j.gie.2020.06.040
3. Jain S, Naicker D, Raj R, Patel V, Hu YC, Srinivasan K, et al. Computational intelligence in cancer diagnostics: a contemporary review of smart phone apps, current problems, and future research potentials. Diagnostics (Basel). 2023;13(9):1563. https://doi.org/10.3390/diagnostics13091563
4. Krizhevsky A, Sutskever I, Hinton GE. ImageNet classification with deep convolutional neural networks. Commun ACM. 2017;60(6):84-90.
5. Rodríguez-Ruiz A, Krupinski E, Mordang JJ, Schilling K, Heywang-Köbrunner SH, Sechopoulos I, et al. Detection of breast cancer with mammography: effect of an artificial intelligence support system. Radiology. 2019;290(2):305-14. https://doi.org/10.1148/radiol.2018181371
6. Eisemann N, Bunk S, Mukama T, Baltus H, Elsner SA, Gomille T, et al. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening. Nat Med. 2025;31(3):917-24. https://doi.org/10.1038/s41591-024-03408-6
7. Kwon MR, Chang Y, Ham SY, Cho Y, Kim EY, Kang J, et al. Screening mammography performance according to breast density: a comparison between radiologists versus standalone intelligence detection. Breast Cancer Res. 2024;26(1):68. https://doi.org/10.1186/s13058-024-01821-w
8. Vourtsis A. Three-dimensional automated breast ultrasound: technical aspects and first results. Diagn Interv Imaging. 2019;100(10):579-92. https://doi.org/10.1016/j.diii.2019.03.012
9. Zhang D, Jiang F, Yin R, Wu GG, Wei Q, Cui XW, et al. A review of the role of the S-detect computer-aided diagnostic ultrasound system in the evaluation of benign and malignant breast and thyroid masses. Med Sci Monit. 2021;27:e931228. https://doi.org/10.12659/MSM.931957
10. Kelly KM, Dean J, Comulada WS, Lee SJ. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol. 2010;20(3):734-42. https://doi.org/10.1007/s00330-009-1588-y
11. Hejduk P, Marcon M, Unkelbach J, Ciritsis A, Rossi C, Borkowski K, et al. Fully automatic classification of automated breast ultrasound (ABUS) imaging according to BI-RADS using a deep convolutional neural network. Eur Radiol. 2022;32(7):4868-78. https://doi.org/10.1007/s00330-022-08558-0
12. Wanderley MC, Soares CMA, Morais MMM, Cruz RM, Lima IRM, Chojniak R, et al. Application of artificial intelligence in predicting malignancy risk in breast masses on ultrasound. Radiol Bras. 2023;56(5):229-34. https://doi.org/10.1590/0100-3984.2023.0034
13. Salim M, Liu Y, Sorkhei M, Ntoula D, Foukakis T, Fredriksson I, et al. AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial. Nat Med. 2024;30(9):2623-630. https://doi.org/10.1038/s41591-024-03093-5
14. Bouchebbah F, Slimani H. 3D automatic levels propagation approach to breast MRI tumor segmentation. Expert Syst Appl. 2021;165:113965. https://doi.org/10.1016/j.eswa.2020.113965
15. Caballo M, Sanderink WBG, Han L, Gao Y, Athanasiou A, Mann RM. Four-dimensional machine learning radiomics for the pretreatment assessment of breast cancer pathologic complete response to neoadjuvant chemotherapy in dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2023;57(1):97-110. https://doi.org/10.1002/jmri.28273
16. Qu YH, Zhu HT, Cao K, Li XT, Ye M, Sun YS. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method. Thorac Cancer. 2020;11(3):651-8. https://doi.org/10.1111/1759-7714.13309
17. Müller-Franzes G, Huck L, Arasteh ST, Khader F, Han T, Schulz V, et al. Using machine learning to reduce the need for contrast agents in breast MRI through synthetic images. Radiology. 2023;307(3):e222211. https://doi.org/10.1148/radiol.222211
18. Chung M, Calabrese E, Mongan J, Ray KM, Hayward JH, Kelil T, et al. Deep learning to simulate contrast-enhanced breast MRI of Invasive Breast Cancer. Radiology. 2023;306(3):e213199. https://doi.org/10.1148/radiol.213199
19. Wong J, Fong A, McVicar N, Smith S, Giambattista J, Wells D, et al. Comparing deep learning-based auto-segmentation of organs at risk and clinical target volumes to expert inter-observer variability in radiotherapy planning. Radiother Oncol. 2020;144:152-8. https://doi.org/10.1016/j.radonc.2019.10.019
20. Nyflot MJ, Thammasorn P, Wootton LS, Ford EC, Chaovalitwongse WA. Deep learning for patient‐specific quality assurance: Identifying errors in radiotherapy delivery by radiomic analysis of gamma images with convolutional neural networks. Med Phys. 2019;46(2):456-64. https://doi.org/10.1002/mp.13338
21. Shen WQ, Guo Y, Ru WE, Li C, Zhang GC, Liao N, et al. Using an improved residual network to identify PIK3CA mutation status in breast cancer on ultrasound image. Front Oncol. 2022;12:864908. https://doi.org/10.3389/fonc.2022.850515
22. Han Z, Wei B, Zheng Y, Yin Y, Li K, Li S. Breast cancer multi-classification from histopathological images with structured deep learning model. Sci Rep. 2017;7(1):4172. https://doi.org/10.1038/s41598-017-04075-z
23. Wu S, Yue M, Zhang J, Li X, Li Z, Zhang H, et al. The role of artificial intelligence in accurate interpretation of HER2 immunohistochemical scores 0 and 1+ in breast cancer. Mod Pathol. 2023;36(3):100054. https://doi.org/10.1016/j.modpat.2022.100054
24. Retamero JA, Gulturk E, Bozkurt A, Liu S, Gorgan M, Moral L, et al. Artificial intelligence helps pathologists increase diagnostic accuracy and efficiency in the detection of breast cancer lymph node metastases. Am J Surg Pathol. 2024;48(7):846-
25. Saliba GAM, Alves JCRR. Use of mobile application as an auxiliary tool in the preoperative marking of nipple-areola complex positioning in mammoplasty. Plast Reconstr Surg Glob Open. 2021;9(11):e3942. https://doi.org/10.1097/GOX.0000000000003942
26. O’Neill AC, Yang D, Roy M, Sebastiampillai S, Hofer SOP, Xu W. Development and evaluation of a machine learning prediction model for flap failure in microvascular breast reconstruction. Ann Surg Oncol. 2020;27(9):3466-75. https://doi.org/10.1245/s10434-020-08307-x
27. Myung Y, Jeon S, Heo C, Kim EK, Kang E, Shin HC, et al. Validating machine learning approaches for prediction of donor related complication in microsurgical breast reconstruction: a retrospective cohort study. Sci Rep. 202;11(1):5615. https://doi.org/10.1038/s41598-021-85155-z
28. Wei X, Lu Q, Jin S, Li F, Zhao Q, Cui Y, et al. Developing and validating a prediction model for lymphedema detection in breast cancer survivors. Eur J Oncol Nurs. 2021;54:102023. https://doi.org/10.1016/j.ejon.2021.102023
29. Conti A, Duggento A, Indovina I, Guerrisi M, Toschi N. Radiomics in breast cancer classification and prediction. Semin Cancer Biol. 2021;72:238-50. https://doi.org/10.1016/j.semcancer.2020.04.002
30. Fernandes JO, Machado BF, Cardoso-Filho C, Nativio J, Cabello C, Vale DB. Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases. BMC Womens Health. 2023;23(1):644. https://doi.org/10.1186/s12905-023-02803-4
31. Geras KJ, Mann RM, Moy L. Artificial intelligence for mammography and digital breast tomosynthesis: current concepts and future perspectives. Radiology. 2019;293(2):246-59. https://doi.org/10.1148/radiol.2019182627
32. Schopf CM, Ramwala OA, Lowry KP, Hofvind S, Marinovich ML, Houssami N, et al. Artificial intelligence-driven mammography-based future breast cancer risk prediction: a systematic review. J Am Coll Radiol. 2024;21(2):319-28. https://doi.org/10.1016/j.jacr.2023.10.018
33. US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, et al. Screening for breast cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2024;331(22):1918-30. https://doi.org/10.1001/jama.2024.5534
34. Çelebi F, Tuncer O, Oral M, Duymaz T, Orhan T, Ertaş G. Artificial intelligence in diagnostic breast ultrasound: a comparative analysis of decision support among radiologists with various levels of expertise. Eur J Breast Health. 2025;21(1):33-9. https://doi.org/10.4274/ejbh.galenos.2024.2024-9-7
35. Medina D, Hazlewood CF, Cleveland GG, Chang DC, Spjut HJ, Moyers R. Nuclear magnetic resonance studies on human breast dysplasias and neoplasms. J Natl Cancer Inst. 1975;54(4):813-8. PMID: 1127715.
36. Lo Gullo R, Marcus E, Huayanay J, Eskreis-Winkler S, Thakur S, Teuwen J, et al. Artificial intelligence-enhanced breast MRI: applications in breast cancer primary treatment response assessment and prediction. Invest Radiol. 2024;59(4):230-42. https://doi.org/10.1097/RLI.0000000000001010
37. Kawamura M, Kamomae T, Yanagawa M, Kamagata K, Fujita S, Ueda D, et al. Revolutionizing radiation therapy: the role of AI in clinical practice. J Radiat Res. 2024;65(1):1-9. https://doi.org/10.1093/jrr/rrad090
38. Poortmans PMP, Takanen S, Marta GN, Meattini I, Kaidar-Person O. Winter is over: the use of artificial intelligence to individualise radiation therapy for breast cancer. Breast. 2020;49:194-200. https://doi.org/10.1016/j.breast.2019.11.011
39. Fey MF. Impact of the Human Genome Project on the clinical management of sporadic cancers. Lancet Oncol. 2002;3(6):349-56. https://doi.org/10.1016/s1470-2045(02)00775-1
40. Bedrosian I, Somerfield MR, Achatz MI, Boughey JC, Curigliano G, Friedman S, et al. Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol. 2024;42(5):584-604. https://doi.org/10.1200/JCO.23.02225
41. Shao J, Ma J, Zhang Q, Li W, Wang C. Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology. Semin Cancer Biol. 2023;91:1-15. https://doi.org/10.1016/j.semcancer.2023.02.006
42. André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, et al. Alpelisib for PIK3CA -mutated, hormone receptor-positive advanced breast cancer. N Engl J Med. 2019;380(20):1929-40. https://doi.org/10.1056/NEJMoa1813904
43. Waqas A, Bui MM, Glassy EF, El Naqa I, Borkowski P, Borkowski AA, et al. Revolutionizing digital pathology with the power of generative artificial intelligence and foundation models. Lab Invest. 2023;103(11):100255. https://doi.org/10.1016/j.labinv.2023.100255
44. Liu Y, Han D, Parwani AV, Li Z. Applications of artificial intelligence in breast pathology. Arch Pathol Lab Med. 2023;147(9):1003-13. https://doi.org/10.5858/arpa.2022-0457-RA
54. https://doi.org/10.1097/PAS.0000000000002248
45. João TBF, Oliveira VM, Bagnoli F, Bastos MCS, Rinaldi JF, Brenelli FP, et al. How well are Brazilian mastologists (breast surgeons) trained in breast reconstruction and oncoplastic surgery? A study of the impact of a breast reconstruction and oncoplastic surgery improvement course. Front Oncol. 2023;13:1139461. https://doi.org/10.3389/fonc.2023.1139461
46. Soh CL, Shah V, Rad AA, Vardanyan R, Zubarevich A, Torabi S, et al. Present and future of machine learning in breast surgery: systematic review. Br J Surg. 2022:109(11):1053-62. https://doi.org/10.1093/bjs/znac224
47. Zhang M, Zhu L, Lin SY, Herr K, Chi CL, Demir I, et al. Using artificial intelligence to improve pain assessment and pain management: a scoping review. J Am Med Inform Assoc. 2023;30(3)570-87. https://doi.org/10.1093/jamia/ocac231
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2026 Virgínia de Assis Silva, Renata Capanema Saliba Franco, Anna Dias Salvador, Waldeir José de Almeida Junior, Gabriel Oliveira Bernardes Gil, Bernardo Bacelar de Faria, Jairo Luiz Coelho Junior, José Tadeu Campos Avelar
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
